{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:44:19Z","timestamp":1794584659825,"version":"4.9.1"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910152- TS180029"],"award-info":[{"award-number":["W81XWH1910152- TS180029"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005963","name":"LAM Foundation","doi-asserted-by":"publisher","award":["LAM0142C01-20"],"award-info":[{"award-number":["LAM0142C01-20"]}],"id":[{"id":"10.13039\/100005963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["U01HL131022"],"award-info":[{"award-number":["U01HL131022"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    mTORC1 is hyperactive in multiple cancer types\n                    <jats:sup>1,2<\/jats:sup>\n                    . Here, we performed integrative analysis of single cell transcriptomic profiling, paired T cell receptor (TCR) sequencing, and spatial transcriptomic profiling on Tuberous Sclerosis Complex (TSC) associated tumors with mTORC1 hyperactivity, and identified a stem-like tumor cell state (SLS) linked to T cell dysfunction via tumor-modulated immunosuppressive macrophages. Rapamycin and its derivatives (rapalogs) are the primary treatments for TSC tumors, and the stem-like tumor cells showed rapamycin resistance in vitro, reminiscent of the cytostatic effects of these drugs in patients. The pro-angiogenic factor midkine (MDK) was highly expressed by the SLS population, and associated with enrichment of endothelial cells in SLS-dominant samples. Inhibition of MDK showed synergistic benefit with rapamycin in reducing the growth of TSC cell lines in vitro and in vivo. In aggregate, this study suggests an autocrine rapamycin resistance mechanism and a paracrine tumor survival mechanism via immune suppression adopted by the stem-like state tumor cells with mTORC1 hyperactivity.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-32673-7","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T05:03:12Z","timestamp":1661490192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment"],"prefix":"10.1038","volume":"13","author":[{"given":"Yan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5668-5219","authenticated-orcid":false,"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-6699","authenticated-orcid":false,"given":"Elizabeth P.","family":"Henske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"32673_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","volume":"45","author":"I Ben-Sahra","year":"2017","unstructured":"Ben-Sahra, I. & Manning, B. D. mTORC1 signaling and the metabolic control of cell growth. Curr. Opin. Cell Biol. 45, 72\u201382 (2017).","journal-title":"Curr. Opin. Cell Biol."},{"key":"32673_CR2","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1716173114","volume":"114","author":"DM Sabatini","year":"2017","unstructured":"Sabatini, D. M. Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc. Natl Acad. Sci. USA 114, 11818\u201311825 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32673_CR3","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske, E. P., Jozwiak, S., Kingswood, J. C., Sampson, J. R. & Thiele, E. A. Tuberous sclerosis complex. Nat. Rev. Dis. Prim. 2, 16035 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"32673_CR4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam, H. C., Siroky, B. J. & Henske, E. P. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat. Rev. Nephrol. 14, 704\u2013716 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"32673_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ccm.2016.04.002","volume":"37","author":"SR Johnson","year":"2016","unstructured":"Johnson, S. R., Taveira-DaSilva, A. M. & Moss, J. Lymphangioleiomyomatosis. Clin. Chest Med. 37, 389\u2013403 (2016).","journal-title":"Clin. Chest Med."},{"key":"32673_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358, 140\u2013151 (2008).","journal-title":"N. Engl. J. Med."},{"key":"32673_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack, F. X. et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N. Engl. J. Med. 364, 1595\u20131606 (2011).","journal-title":"N. Engl. J. Med."},{"key":"32673_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin, K. R. et al. The genomic landscape of tuberous sclerosis complex. Nat. Commun. 8, 15816 (2017).","journal-title":"Nat. Commun."},{"key":"32673_CR9","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20190251","volume":"216","author":"M Zarei","year":"2019","unstructured":"Zarei, M. et al. Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion. J. Exp. Med. 216, 2635\u20132652 (2019).","journal-title":"J. Exp. Med."},{"key":"32673_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1164\/rccm.201912-2445OC","volume":"202","author":"M Guo","year":"2020","unstructured":"Guo, M. et al. Single-cell transcriptomic analysis identifies a unique pulmonary lymphangioleiomyomatosis cell. Am. J. Respir. Crit. Care Med. 202, 1373\u20131387 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32673_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18979-4","volume":"11","author":"K Obraztsova","year":"2020","unstructured":"Obraztsova, K. et al. mTORC1 activation in lung mesenchyme drives sex- and age-dependent pulmonary structure and function decline. Nat. Commun. 11, 5640 (2020).","journal-title":"Nat. Commun."},{"key":"32673_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12015-019-09942-y","volume":"16","author":"PK Das","year":"2020","unstructured":"Das, P. K. et al. Plasticity of cancer stem cell: origin and role in disease progression and therapy resistance. Stem Cell Rev. Rep. 16, 397\u2013412 (2020).","journal-title":"Stem Cell Rev. Rep."},{"key":"32673_CR13","doi-asserted-by":"crossref","unstructured":"Kwiatkowski D.J., Thiele E.A., Whittemore V.H. Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. 1. Aufl. ed. Hoboken: Wiley-BlackwellJohn Wiley & Sons, Incorporated; 2010.","DOI":"10.1002\/9783527630073"},{"key":"32673_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/ncb3465","volume":"19","author":"G Fluegen","year":"2017","unstructured":"Fluegen, G. et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat. Cell Biol. 19, 120\u2013132 (2017).","journal-title":"Nat. Cell Biol."},{"key":"32673_CR15","doi-asserted-by":"crossref","unstructured":"Tang Y., Kwiatkowski D.J., Henske E.P. mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19. Eur. Respir. J. 57, 2002737 (2021).","DOI":"10.1183\/13993003.02737-2020"},{"key":"32673_CR16","doi-asserted-by":"publisher","first-page":"e87270","DOI":"10.1172\/jci.insight.87270","volume":"1","author":"AR Osterburg","year":"2016","unstructured":"Osterburg, A. R. et al. NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline. JCI Insight 1, e87270 (2016).","journal-title":"JCI Insight"},{"key":"32673_CR17","doi-asserted-by":"crossref","unstructured":"Liu, H. J. et al. TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1\/anti-CTLA-4 immunotherapy. JCI Insight. 3, e98674 (2018).","DOI":"10.1172\/jci.insight.98674"},{"key":"32673_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1165\/rcmb.2018-0123OC","volume":"59","author":"K Maisel","year":"2018","unstructured":"Maisel, K. et al. Immune checkpoint ligand PD-L1 is upregulated in pulmonary lymphangioleiomyomatosis. Am. J. Respir. Cell Mol. Biol. 59, 723\u2013732 (2018).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"32673_CR19","doi-asserted-by":"publisher","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","volume":"12","author":"K Giannikou","year":"2016","unstructured":"Giannikou, K. et al. Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development. PLoS Genet. 12, e1006242 (2016).","journal-title":"PLoS Genet."},{"key":"32673_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/00000478-199710000-00001","volume":"21","author":"JN Eble","year":"1997","unstructured":"Eble, J. N., Amin, M. B. & Young, R. H. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am. J. Surg. Pathol. 21, 1123\u20131130 (1997).","journal-title":"Am. J. Surg. Pathol."},{"key":"32673_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000451013","volume":"92","author":"H Tochio","year":"2017","unstructured":"Tochio, H. et al. CD68-positive cells in hepatic angiomyolipoma. Oncology 92, 35\u201339 (2017).","journal-title":"Oncology"},{"key":"32673_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1084\/jem.20042469","volume":"202","author":"S Li","year":"2005","unstructured":"Li, S. et al. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J. Exp. Med. 202, 617\u2013624 (2005).","journal-title":"J. Exp. Med."},{"key":"32673_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"32673_CR24","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI58709","volume":"122","author":"EP Henske","year":"2012","unstructured":"Henske, E. P. & McCormack, F. X. Lymphangioleiomyomatosis - a wolf in sheep\u2019s clothing. J. Clin. Invest. 122, 3807\u20133816 (2012).","journal-title":"J. Clin. Invest."},{"key":"32673_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/modpathol.2008.189","volume":"22","author":"M Chilosi","year":"2009","unstructured":"Chilosi, M. et al. Cathepsin-k expression in pulmonary lymphangioleiomyomatosis. Mod. Pathol. 22, 161\u2013166 (2009).","journal-title":"Mod. Pathol."},{"key":"32673_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1165\/ajrcmb.21.3.3693","volume":"21","author":"Y Matsumoto","year":"1999","unstructured":"Matsumoto, Y. et al. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am. J. Respir. Cell Mol. Biol. 21, 327\u2013336 (1999).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"32673_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/01.pas.0000126859.70814.6d","volume":"28","author":"T Kumasaka","year":"2004","unstructured":"Kumasaka, T. et al. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am. J. Surg. Pathol. 28, 1007\u20131016 (2004).","journal-title":"Am. J. Surg. Pathol."},{"key":"32673_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1056\/NEJMc0707517","volume":"358","author":"LR Young","year":"2008","unstructured":"Young, L. R., Inoue, Y. & McCormack, F. X. Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N. Engl. J. Med. 358, 199\u2013200 (2008).","journal-title":"N. Engl. J. Med."},{"key":"32673_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5858\/2008-0542-RAR1.1","volume":"134","author":"G Martignoni","year":"2010","unstructured":"Martignoni, G. et al. Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors. Arch. Pathol. Lab. Med. 134, 33\u201340 (2010).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"32673_CR30","first-page":"699","volume":"11","author":"PA Fetsch","year":"1998","unstructured":"Fetsch, P. A. et al. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor. Mod. Pathol. 11, 699\u2013703 (1998).","journal-title":"Mod. Pathol."},{"key":"32673_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/onc.2014.18","volume":"34","author":"C Rupp","year":"2015","unstructured":"Rupp, C. et al. IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction. Oncogene 34, 815\u2013825 (2015).","journal-title":"Oncogene"},{"key":"32673_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10549-016-3929-2","volume":"159","author":"CK Park","year":"2016","unstructured":"Park, C. K., Jung, W. H. & Koo, J. S. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. Breast Cancer Res. Treat. 159, 55\u201369 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"32673_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"32673_CR34","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 e1821 (2019).","journal-title":"Cell"},{"key":"32673_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"32673_CR36","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-16-2458","volume":"77","author":"HC Lam","year":"2017","unstructured":"Lam, H. C. et al. p62\/SQSTM1 cooperates with hyperactive mTORC1 to regulate glutathione production, maintain mitochondrial integrity, and promote tumorigenesis. Cancer Res. 77, 3255\u20133267 (2017).","journal-title":"Cancer Res."},{"key":"32673_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1165\/rcmb.2009-0050OC","volume":"42","author":"PS Lee","year":"2010","unstructured":"Lee, P. S. et al. Rapamycin-insensitive up-regulation of MMP2 and other genes in tuberous sclerosis complex 2-deficient lymphangioleiomyomatosis-like cells. Am. J. Respir. Cell Mol. Biol. 42, 227\u2013234 (2010).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"32673_CR38","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1158\/1541-7786.MCR-17-0077","volume":"15","author":"C Li","year":"2017","unstructured":"Li, C. et al. Tuberin regulates prostaglandin receptor-mediated viability, via Rheb, in mTORC1-hyperactive cells. Mol. Cancer Res. 15, 1318\u20131330 (2017).","journal-title":"Mol. Cancer Res."},{"key":"32673_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"32673_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224\u2013236 (2008).","journal-title":"Cell Metab."},{"key":"32673_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1165\/rcmb.2014-0379RC","volume":"53","author":"C Priolo","year":"2015","unstructured":"Priolo, C. et al. Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis. Am. J. Respir. Cell Mol. Biol. 53, 33\u201341 (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"32673_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-9-69","volume":"9","author":"A Csibi","year":"2011","unstructured":"Csibi, A. & Blenis, J. Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors. BMC Biol. 9, 69 (2011).","journal-title":"BMC Biol."},{"key":"32673_CR43","doi-asserted-by":"publisher","first-page":"e6189","DOI":"10.1371\/journal.pone.0006189","volume":"4","author":"HH Zhang","year":"2009","unstructured":"Zhang, H. H. et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 4, e6189 (2009).","journal-title":"PLoS One"},{"key":"32673_CR44","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neo.2018.12.003","volume":"21","author":"AT Jones","year":"2019","unstructured":"Jones, A. T., Narov, K., Yang, J., Sampson, J. R. & Shen, M. H. Efficacy of dual inhibition of glycolysis and glutaminolysis for therapy of renal lesions in Tsc2(+\/-) mice. Neoplasia 21, 230\u2013238 (2019).","journal-title":"Neoplasia"},{"key":"32673_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"32673_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5858\/2002-126-0049-MMIAOT","volume":"126","author":"HR Makhlouf","year":"2002","unstructured":"Makhlouf, H. R. et al. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study. Arch. Pathol. Lab. Med. 126, 49\u201355 (2002).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"32673_CR47","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.5858\/2002-126-1157a-MMIA","volume":"126","author":"D Villari","year":"2002","unstructured":"Villari, D., Grosso, M., Vitarelli, E., Tuccari, G. & Barresi, G. Melanoma markers in angiomyolipoma. Arch. Pathol. Lab. Med. 126, 1157 (2002).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"32673_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24499-6","volume":"12","author":"N Alesi","year":"2021","unstructured":"Alesi, N. et al. TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nat. Commun. 12, 4245 (2021).","journal-title":"Nat. Commun."},{"key":"32673_CR49","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.25537","volume":"55","author":"K Kim","year":"2012","unstructured":"Kim, K., Pyo, S. & Um, S. H. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver. Hepatology 55, 1727\u20131737 (2012).","journal-title":"Hepatology"},{"key":"32673_CR50","doi-asserted-by":"publisher","first-page":"F560","DOI":"10.1152\/ajprenal.00569.2013","volume":"307","author":"BJ Siroky","year":"2014","unstructured":"Siroky, B. J. et al. Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy. Am. J. Physiol. Ren. Physiol. 307, F560\u2013F570 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"32673_CR51","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1091\/mbc.E14-10-1443","volume":"26","author":"J Luo","year":"2015","unstructured":"Luo, J. et al. Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK). Mol. Biol. Cell 26, 430\u2013439 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"32673_CR52","doi-asserted-by":"publisher","first-page":"37124","DOI":"10.1074\/jbc.M405254200","volume":"279","author":"PR Reynolds","year":"2004","unstructured":"Reynolds, P. R., Mucenski, M. L., Le Cras, T. D., Nichols, W. C. & Whitsett, J. A. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J. Biol. Chem. 279, 37124\u201337132 (2004).","journal-title":"J. Biol. Chem."},{"key":"32673_CR53","doi-asserted-by":"crossref","unstructured":"Filippou P.S., Karagiannis G.S., Constantinidou A. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target. Oncogene. 39, 2040\u20132054 (2019).","DOI":"10.1038\/s41388-019-1124-8"},{"key":"32673_CR54","first-page":"1814","volume":"57","author":"R Choudhuri","year":"1997","unstructured":"Choudhuri, R., Zhang, H. T., Donnini, S., Ziche, M. & Bicknell, R. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res. 57, 1814\u20131819 (1997).","journal-title":"Cancer Res."},{"key":"32673_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature22977","volume":"546","author":"D Olmeda","year":"2017","unstructured":"Olmeda, D. et al. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature 546, 676\u2013680 (2017).","journal-title":"Nature"},{"key":"32673_CR56","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","volume":"25","author":"RC Wirka","year":"2019","unstructured":"Wirka, R. C. et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat. Med. 25, 1280\u20131289 (2019).","journal-title":"Nat. Med."},{"key":"32673_CR57","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan, H. et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 47, D900\u2013D908 (2019).","journal-title":"Nucleic Acids Res."},{"key":"32673_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature03232","volume":"433","author":"F Alvarez-Vasquez","year":"2005","unstructured":"Alvarez-Vasquez, F. et al. Simulation and validation of modelled sphingolipid metabolism in Saccharomyces cerevisiae. Nature 433, 425\u2013430 (2005).","journal-title":"Nature"},{"key":"32673_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0025-5564(98)10001-9","volume":"151","author":"R Curto","year":"1998","unstructured":"Curto, R., Voit, E. O., Sorribas, A. & Cascante, M. Mathematical models of purine metabolism in man. Math. Biosci. 151, 1\u201349 (1998).","journal-title":"Math. Biosci."},{"key":"32673_CR60","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.bbadis.2017.10.023","volume":"1864","author":"Y Tang","year":"2018","unstructured":"Tang, Y. et al. Metabolic modeling helps interpret transcriptomic changes during malaria. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2329\u20132340 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"32673_CR61","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.celrep.2017.05.043","volume":"19","author":"N Emmanuel","year":"2017","unstructured":"Emmanuel, N. et al. Purine nucleotide availability regulates mTORC1 activity through the Rheb GTPase. Cell Rep. 19, 2665\u20132680 (2017).","journal-title":"Cell Rep."},{"key":"32673_CR62","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.celrep.2017.10.029","volume":"21","author":"G Hoxhaj","year":"2017","unstructured":"Hoxhaj, G. et al. The mTORC1 signaling network senses changes in cellular purine nucleotide levels. Cell Rep. 21, 1331\u20131346 (2017).","journal-title":"Cell Rep."},{"key":"32673_CR63","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.chest.2019.05.038","volume":"156","author":"Y Tang","year":"2019","unstructured":"Tang, Y. et al. Alterations in polyamine metabolism in patients with lymphangioleiomyomatosis and tuberous sclerosis complex 2-deficient cells. Chest 156, 1137\u20131148 (2019).","journal-title":"Chest"},{"key":"32673_CR64","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/s41388-018-0589-1","volume":"38","author":"T Nishimura","year":"2019","unstructured":"Nishimura, T. et al. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2. Oncogene 38, 2464\u20132481 (2019).","journal-title":"Oncogene"},{"key":"32673_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier, C., Baker, D., Ten Dijke, P. & Ritsma, L. TGF-beta family signaling pathways in cellular dormancy. Trends Cancer 5, 66\u201378 (2019).","journal-title":"Trends Cancer"},{"key":"32673_CR66","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan, T. G. & Croucher, P. I. The dormant cancer cell life cycle. Nat. Rev. Cancer 20, 398\u2013411 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"32673_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-1049-0","volume":"20","author":"E Borgen","year":"2018","unstructured":"Borgen, E. et al. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients. Breast Cancer Res. 20, 120 (2018).","journal-title":"Breast Cancer Res."},{"key":"32673_CR68","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1073\/pnas.0810790106","volume":"106","author":"JJ Yu","year":"2009","unstructured":"Yu, J. J. et al. Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells. Proc. Natl Acad. Sci. USA 106, 2635\u20132640 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32673_CR69","doi-asserted-by":"publisher","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","volume":"286","author":"J Yu","year":"2004","unstructured":"Yu, J., Astrinidis, A., Howard, S. & Henske, E. P. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am. J. Physiol. Lung Cell Mol. Physiol. 286, L694\u2013L700 (2004).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"32673_CR70","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo, T., Astrinidis, A. & Henske, E. P. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 97, 6085\u20136090 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32673_CR71","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1378\/chest.08-1160","volume":"135","author":"CG Glasgow","year":"2009","unstructured":"Glasgow, C. G., Avila, N. A., Lin, J. P., Stylianou, M. P. & Moss, J. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement. Chest 135, 1293\u20131300 (2009).","journal-title":"Chest"},{"key":"32673_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/pros.20672","volume":"68","author":"H Gustavsson","year":"2008","unstructured":"Gustavsson, H., Jennbacken, K., Welen, K. & Damber, J. E. Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer. Prostate 68, 161\u2013170 (2008).","journal-title":"Prostate"},{"key":"32673_CR73","doi-asserted-by":"crossref","unstructured":"De Angelis M.L., Francescangeli F., La Torre F., Zeuner A. Stem cell plasticity and dormancy in the development of cancer therapy resistance. Front. Oncol. 9, 626 (2019).","DOI":"10.3389\/fonc.2019.00626"},{"key":"32673_CR74","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader, J. E. & Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755\u2013768 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"32673_CR75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275\u2013284 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"32673_CR76","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso, J. A. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834\u2013846 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"32673_CR77","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1038\/sj.onc.1208671","volume":"24","author":"BL Mirkin","year":"2005","unstructured":"Mirkin, B. L. et al. Identification of midkine as a mediator for intercellular transfer of drug resistance. Oncogene 24, 4965\u20134974 (2005).","journal-title":"Oncogene"},{"key":"32673_CR78","doi-asserted-by":"publisher","first-page":"154ra134","DOI":"10.1126\/scitranslmed.3003840","volume":"4","author":"EA Goncharova","year":"2012","unstructured":"Goncharova, E. A. et al. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM). Sci. Transl. Med. 4, 154ra134 (2012).","journal-title":"Sci. Transl. Med."},{"key":"32673_CR79","doi-asserted-by":"publisher","first-page":"e71093","DOI":"10.1371\/journal.pone.0071093","volume":"8","author":"H Hao","year":"2013","unstructured":"Hao, H. et al. Inhibition of the growth factor MDK\/midkine by a novel small molecule compound to treat non-small cell lung cancer. PLoS One 8, e71093 (2013).","journal-title":"PLoS One"},{"key":"32673_CR80","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-020-1073-3","volume":"26","author":"D Cerezo-Wallis","year":"2020","unstructured":"Cerezo-Wallis, D. et al. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state. Nat. Med. 26, 1865\u20131877 (2020).","journal-title":"Nat. Med."},{"key":"32673_CR81","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/msb.2011.71","volume":"7","author":"M Cokol","year":"2011","unstructured":"Cokol, M. et al. Systematic exploration of synergistic drug pairs. Mol. Syst. Biol. 7, 544 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"32673_CR82","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/S1462399410001766","volume":"13","author":"L Kalan","year":"2011","unstructured":"Kalan, L. & Wright, G. D. Antibiotic adjuvants: multicomponent anti-infective strategies. Expert Rev. Mol. Med. 13, e5 (2011).","journal-title":"Expert Rev. Mol. Med."},{"key":"32673_CR83","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1073\/pnas.1818210116","volume":"116","author":"A Miranda","year":"2019","unstructured":"Miranda, A. et al. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. Proc. Natl Acad. Sci. USA 116, 9020\u20139029 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32673_CR84","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.4049\/jimmunol.168.4.1528","volume":"168","author":"KE Foulds","year":"2002","unstructured":"Foulds, K. E. et al. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168, 1528\u20131532 (2002).","journal-title":"J. Immunol."},{"key":"32673_CR85","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."},{"key":"32673_CR86","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.celrep.2018.10.047","volume":"25","author":"MP Kumar","year":"2018","unstructured":"Kumar, M. P. et al. Analysis of single-cell RNA-seq identifies cell-cell communication associated with tumor characteristics. Cell Rep. 25, 1458\u20131468 e1454 (2018).","journal-title":"Cell Rep."},{"key":"32673_CR87","doi-asserted-by":"crossref","unstructured":"Lu, W. et al. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. EMBO Mol. Med. 13, e12798 (2020).","DOI":"10.15252\/emmm.202012798"},{"key":"32673_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41590-019-0563-2","volume":"21","author":"KM Mahoney","year":"2020","unstructured":"Mahoney, K. M. & Freeman, G. J. Acidity changes immunology: a new VISTA pathway. Nat. Immunol. 21, 13\u201316 (2020).","journal-title":"Nat. Immunol."},{"key":"32673_CR89","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12520","volume":"276","author":"M Das","year":"2017","unstructured":"Das, M., Zhu, C. & Kuchroo, V. K. Tim-3 and its role in regulating anti-tumor immunity. Immunol. Rev. 276, 97\u2013111 (2017).","journal-title":"Immunol. Rev."},{"key":"32673_CR90","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"32673_CR91","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","volume":"37","author":"SC Starossom","year":"2012","unstructured":"Starossom, S. C. et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37, 249\u2013263 (2012).","journal-title":"Immunity"},{"key":"32673_CR92","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","volume":"31","author":"D Baitsch","year":"2011","unstructured":"Baitsch, D. et al. Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler. Thromb. Vasc. Biol. 31, 1160\u20131168 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"32673_CR93","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. TREM2 is a receptor for beta-amyloid that mediates microglial function. Neuron 97, 1023\u20131031 e1027 (2018).","journal-title":"Neuron"},{"key":"32673_CR94","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","volume":"3","author":"Q Peng","year":"2010","unstructured":"Peng, Q. et al. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci. Signal. 3, ra38 (2010).","journal-title":"Sci. Signal."},{"key":"32673_CR95","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663 e613 (2017).","journal-title":"Cell"},{"key":"32673_CR96","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora, M. et al. TREM2 modulation remodels the tumor myeloid landscape enhancing anti-PD-1 immunotherapy. Cell 182, 886\u2013900 e817 (2020).","journal-title":"Cell"},{"key":"32673_CR97","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","volume":"182","author":"Y Katzenelenbogen","year":"2020","unstructured":"Katzenelenbogen, Y. et al. Coupled scRNA-seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in Cancer. Cell 182, 872\u2013885 e819 (2020).","journal-title":"Cell"},{"key":"32673_CR98","doi-asserted-by":"crossref","unstructured":"Leung, G. A. et al. The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development. Development. 146, dev176180 (2019).","DOI":"10.1242\/dev.176180"},{"key":"32673_CR99","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-18-1367","volume":"78","author":"M Yang","year":"2018","unstructured":"Yang, M., McKay, D., Pollard, J. W. & Lewis, C. E. Diverse functions of macrophages in different tumor microenvironments. Cancer Res. 78, 5492\u20135503 (2018).","journal-title":"Cancer Res."},{"key":"32673_CR100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cellimm.2017.03.006","volume":"316","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Glycoprotein non-metastatic melanoma protein b (Gpnmb) is highly expressed in macrophages of acute injured kidney and promotes M2 macrophages polarization. Cell Immunol. 316, 53\u201360 (2017).","journal-title":"Cell Immunol."},{"key":"32673_CR101","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria, A., Madrigal, J. A. & Saudemont, A. B cell regulation in cancer and anti-tumor immunity. Cell Mol. Immunol. 14, 662\u2013674 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"32673_CR102","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2217\/imt.12.126","volume":"4","author":"J Patel","year":"2012","unstructured":"Patel, J., Bozeman, E. N. & Selvaraj, P. Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors. Immunotherapy 4, 1795\u20131798 (2012).","journal-title":"Immunotherapy"},{"key":"32673_CR103","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2017.11.019","volume":"33","author":"A de Mingo Pulido","year":"2018","unstructured":"de Mingo Pulido, A. et al. TIM-3 regulates CD103(+) dendritic cell function and response to chemotherapy in breast cancer. Cancer Cell 33, 60\u201374 e66 (2018).","journal-title":"Cancer Cell"},{"key":"32673_CR104","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"32673_CR105","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1038\/onc.2009.352","volume":"27","author":"S Menon","year":"2008","unstructured":"Menon, S. & Manning, B. D. Common corruption of the mTOR signaling network in human tumors. Oncogene 27, S43\u2013S51 (2008). Suppl 2(0 2).","journal-title":"Oncogene"},{"key":"32673_CR106","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/jcp.24351","volume":"228","author":"A Alayev","year":"2013","unstructured":"Alayev, A. & Holz, M. K. mTOR signaling for biological control and cancer. J. Cell Physiol. 228, 1658\u20131664 (2013).","journal-title":"J. Cell Physiol."},{"key":"32673_CR107","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin, D. A. & Sabatini, D. M. Defining the role of mTOR in cancer. Cancer Cell 12, 9\u201322 (2007).","journal-title":"Cancer Cell"},{"key":"32673_CR108","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1158\/1078-0432.CCR-1025-3","volume":"10","author":"HC Kang","year":"2004","unstructured":"Kang, H. C. et al. Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin. Cancer Res. 10, 272\u2013284 (2004).","journal-title":"Clin. Cancer Res."},{"key":"32673_CR109","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.humpath.2008.08.010","volume":"40","author":"SM Bonsib","year":"2009","unstructured":"Bonsib, S. M., Moghadamfalahi, M. & Bhalodia, A. Lymphatic differentiation in renal angiomyolipomas. Hum. Pathol. 40, 374\u2013380 (2009).","journal-title":"Hum. Pathol."},{"key":"32673_CR110","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1378\/chest.10-0573","volume":"138","author":"LR Young","year":"2010","unstructured":"Young, L. R. et al. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest 138, 674\u2013681 (2010).","journal-title":"Chest"},{"key":"32673_CR111","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu Rev. Immunol."},{"key":"32673_CR112","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"32673_CR113","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"32673_CR114","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3389\/fimmu.2020.01680","volume":"11","author":"P De Cicco","year":"2020","unstructured":"De Cicco, P., Ercolano, G. & Ianaro, A. The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion. Front. Immunol. 11, 1680\u20131680 (2020).","journal-title":"Front. Immunol."},{"key":"32673_CR115","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"32673_CR116","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"32673_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8866","volume":"6","author":"JA Ramilowski","year":"2015","unstructured":"Ramilowski, J. A. et al. A draft network of ligand-receptor-mediated multicellular signalling in human. Nat. Commun. 6, 7866 (2015).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32673-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32673-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32673-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T06:12:39Z","timestamp":1661494359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32673-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32673"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32673-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5018"}}